NECVAXNEO-1(NEC Corporation/VAXIMM)
N/A
Report date: 2024/10/12 20:00:06
Base Information
Drug NameNECVAXNEO-1(NEC Corporation/VAXIMM)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNec CorpVaximm Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesNEC Bio BVNEC OncoImmunity AS
Inactive CompaniesNec CorpVaximm Gmbh
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A